Search

Search Constraints

You searched for: Author/Creator Vaidyanathan, Sivakumar

Search Results

3. A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19. (4th May 2021)

4. Acceptor Interlocked Molecular Design for Solution‐Processed Stable Deep‐Blue TADF and Hyper Fluorescence Organic LED Enabling High‐Efficiency. Issue 18 (3rd July 2022)

7. Deep-blue emitters (CIEy ∼0.07) based on phenanthroimidazole: Remarkable substitution effects at the N1 position of imidazole on the excited states and electroluminescence properties. (December 2021)